SKN | Parabilis Medicines Raises $670 Million in Upsized IPO as Cancer Drug Candidate Shows Strong Early Results
Key Points:
Parabilis Medicines raised $670 million after pricing its upsized IPO at $20 per share, above the marketed range of $17 to $19.
...
SKN | ERock Prices $600 Million IPO at $21.50 Per Share, Meeting Midpoint Expectations
Natural gas power generation systems provider ERock has successfully priced its initial public offering (IPO) at $21.50 per share, the midpoint of its marketed...
SKN | Parabilis Medicines, Inc. IPO Signals High-Stakes Entry Into Biotech’s Rare Disease Therapeutics Market
Lead Paragraph
Parabilis Medicines, Inc. is advancing toward its IPO market debut with revised offering terms and a reduced share count, reflecting cautious investor sentiment...
SKN | Nuvalent Shares Surge Nearly 40% as Precision Oncology Pipeline Drives Investor Enthusiasm
Nuvalent, Inc. (NASDAQ: NUVL) captured significant investor attention after its shares surged more than 39% in a single trading session, reflecting growing confidence in...
SKN | WhiteHawk Minerals Prices Upsized IPO at $26 Per Share, Raising $200 Million for Natural Gas Royalty Expansion
Natural gas mineral and royalty company WhiteHawk Minerals has successfully priced its upsized initial public offering (IPO), raising approximately $200 million after increasing the...